“nektar-therapeutics” Archives

in
Entry Author Date Location
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs 05/23/19 San Francisco
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost 02/14/18 New York
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Few Opioid Alternatives In Sight as Crisis Gains Political Attention 11/01/17 National
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug 06/01/16 San Francisco
Dear Biopharma: Give Us Better Therapies for Pain 03/23/16 Boston
West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More 10/08/15 Boston
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
West Coast Biotech Roundup: Zymeworks, Lee Hood, Sue Biggins, Nektar 01/22/15 Seattle
An Entrepreneur Grows Along With Ireland’s Medtech Cluster: Galway 10/29/14 National
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
Page 1 of 2 next page »